A novel radiopharmaceutical for detection of malignant melanoma, based on melanin formation: 3-iodo-4-hydroxyphenyl-l-cysteine

Nuclear Medicine Communications

Volumn 24, Issue 5, 2003, Pages 575-582

  Nishii, R ^a   Kawai, K ^a   Flores, L GARCIA ^a   Kataoka, H ^a   Jinnouchi, S ^a   Nagamachi, S ^a   Arano, Y ^a   Tamura, S ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

3 I iodo 4 hydroxyphenyl L cysteine; Amino acid radiopharmaceutical; Malignant melanoma; Tyrosinase

Indexed keywords

3 IODO 4 HYDROXYPHENYLCYSTEINE; 3-IODO-4-HYDROXYPHENYLCYSTEINE; CYSTEINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; MELANIN; RADIOPHARMACEUTICAL AGENT;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; EVALUATION; ISOTOPE LABELING; MELANOMA; METABOLISM; METHODOLOGY; MOUSE; PREDICTION AND FORECASTING; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SKIN TUMOR; SYNTHESIS; TISSUE DISTRIBUTION; WHOLE BODY COUNTING;

ANIMALS; CYSTEINE; ISOTOPE LABELING; MELANINS; MELANOMA; MICE; MICE, INBRED C57BL; ORGAN SPECIFICITY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SKIN NEOPLASMS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; WHOLE-BODY COUNTING;

EID: 1542495699     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200305000-00015     Document Type: Article

References (20)

1. Jimbow K, Miura T, Ito S, Ishikawa K. Phenolic melanin precursors provide a rational approach to design of antitumor agents for melanoma. Pig Cell Res 1989; 2: 34-39.
2. Graham GD, Tiffany SM, Vogel FS. The toxicity of melanin precursors. J Invest Dermatol 1978; 70: 113-116.
3. Wick MM. Levodopa and dopamine analogs as DNA polymerase inhibitors and antitumor agents in human melanoma. Cancer Res 1980; 40: 1414-1418.
4. Yamada K, Jimbow K, Engelhardt R, Ito S. Selective cytotoxicity of phenolic melanin precursor, 4-S-cysteamynylphenol, on in vitro melanoma cell. Biochem Pharmacol 1989; 38: 2217-2221.
5. Ito S, Inoue S, Yamamoto Y, Fujita K. Synthesis and antitumor activity of cysteinyl-3,4-dihydroxyphenylalanines and related compounds. J Med Chem 1981; 24: 673-677.
6. Miura S, Ueda T, Jimbow K, Ito S, Fujita K. Synthesis of cysteinylphenol, cysteaminylphenol, and related compounds, and in vivo evaluation of antimelanoma effect. Arch Dermatol Res 1987; 279: 219-225.
7. Ito S, Kato T, Ishikawa K, Kasuga T, Jimbow K. Mechanism of selective toxicity of 4-S-cysteinylphenol and 4-S-cysteaminylphenol to melanocytes. Biochem Pharmacol 1987; 36: 2007-2011.
8. Hoefnagel CA. Role of nuclear medicine in melanoma. Eur J Nucl Med 1998; 25: 1567-1574.
9. Kawai K, Fujibayashi Y, Saji H, et al. A strategy for the study of cerebral amino acid transport using iodine-123-labeled amino acid radiopharmaceutical: 3-iodo-alpha-methyl-L-tyrosine. J Nucl Med 1991; 32: 819-824.
10. 123I-3-iodo-alpha-methyl-L-tyrosine. Anal Nucl Med 1992; 6: 169-175.
11. Jager PL, Franssen EJF, Kool W, et al. Feasibility of tumor imaging using L-3-[iodine-123]-iodo-α-methyl-tyrosine in experimental tumors. J Nucl Med 1998; 39: 1736-1743.
12. 123I]iodo-alpha-methyl-tyrosine: competition with natural L-amino acids. J Nucl Med 1991; 32: 1225-1228.
13. Kawai K, Flores II LG, Nakagawa M, et al. Brain uptake of iodinated L-meta-tyrosine, a metabolically stable amino acid derivative. Nucl Med Commun 1999; 20: 153-157.
14. 14C]phenol, an experimental antimelanoma agent. Appl Radiat Isot 1989; 40: 539-540.
15. Menon IA, Haberman HF. Isolation of melanin granules. Methods Enzymol 1974; 31: 389-394.
16. Pawelek JM. Factors regulating growth and pigmentation of melanoma cells. J Invest Dermatol 1976; 66: 201-209.
17. Jimbow K, Ito S, Maeda K, et al. Mechanism regulating selective growth inhibition disintegration of melanoma cells by 4-S-cysteinyl phenol and related compounds. J Invest Dermatol 1985; 84: 355-360.
18. Hughes CCW, Lantos PL. Uptake of leucine and alanine by cultured cerebral capillary endothelial cells. Brain Res 1989; 480: 126-132.
19. Oxender DL, Christensen HN. Distinct mediating systems for the transport of neutral amino acids by the Ehrlich cell. J Biol Chem 1963; 238: 3686-3699.
20. Prezioso JA, Epperly MN, Wang N, Bloomer WD. Effects of tyrosinase activity on the cytotoxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol in melanoma cells. Cancer Lett 1992; 63: 73-79.